MS, University of Cincinnati, 2021, Medicine: Clinical and Translational Research
Importance: A robust prediction rule exists for clinical investigation of serious or invasive bacterial infection in infants 60 days and younger, but real-time measurement of procalcitonin is necessary for application of this rule. For clinicians unable to apply the existing prediction rule, the significance of leukopenia (WBC count <5000 cells/µL) in identifying SBI and IBI is unclear.
Objective: To estimate the probability of SBI and IBI in febrile infants 60 days and younger with leukopenia or neutropenia.
Design, Setting, and Participants: Secondary analysis of two combined prospective, observational cohort studies. Convenience samples of febrile infants 60 days and younger were collected at 26 North American emergency departments. Data were analyzed between July 2020 and February 2021.
Exposures: Clinical data including age, qualifying fever temperature, and Yale Observation Scale score, as well as laboratory data including WBC count, ANC, urinalysis, and serum procalcitonin (PCT); multivariable logistic regression was performed using these predictors.
Main Outcomes and Measures: SBIs, defined as culture-positive urinary tract infection, bacteremia, or bacterial meningitis, and, IBIs, defined as bacteremia or bacterial meningitis.
Results: Of 7407 eligible participants, we estimated odds of SBIs and IBIs in 6865 febrile infants 60 days and younger with leukopenia and neutropenia without inclusion of serum PCT levels (complete cohort) and 3098 with serum PCT levels (PCT cohort). We used the commonly accepted WBC count range of 5000-15000 cells/µL as normal reference and found WBC count <2500 cells/µL significantly increased the odds of SBIs (OR 23.77, 95% CI 6.05-74.09, p<0.001) and IBIs (OR 13.48, 95% CI 2.92-45.35, p=0.012) in the complete cohort. This relationship did not hold true for WBC count 2501-5000 cells/µL, nor for any degree of neutropenia, in either the complete or PCT cohorts.
Conclusions and Relevance: WBC count <250 (open full item for complete abstract)
Committee: Scott Langevin Ph.D. (Committee Chair); Michelle Eckerle M.D. (Committee Member); John VanBuren Ph.D (Committee Member)
Subjects: Surgery